A growing understanding of the benefits of exercise over the past few decades has
prompted researchers to take an interest in the possibilities of exercise therapy. Because …

Skeletal muscle mass and muscle function are negatively affected by a variety of conditions
inherent to chronic kidney disease (CKD) and to dialysis treatment. Skeletal muscle mass …

This is an opportune time to publish the first KDIGO 2020 Clinical Practice Guideline for
Diabetes Management in Chronic Kidney Disease (CKD). Worldwide, the estimated number …

Background Sarcopenia, a degenerative and generalized skeletal muscle disorder involving
the loss of muscle function and mass, is an under‐recognized problem in clinical practice …

Skeletal muscle is the most abundant body tissue accounting for many physiological
functions. However, muscle mass and functions are not routinely assessed. Sarcopenia is …

Sarcopenia, now with its own International Classification of Diseases, 10th Revision (ICD-
10) code, is of importance clinically and should be accounted for in research studies in …

Frailty is a condition that is frequently observed among patients undergoing dialysis. Frailty
is characterized by a decline in both physiological state and cognitive state, leading to a …

Background & aims Sarcopenia is a risk factor for adverse outcomes in older adults, but this
has yet to be confirmed in chronic kidney disease (CKD). We conducted a systematic review …

Objectives Slow gait speed may be associated with premature mortality, cardiovascular
disease (CVD), and cancer, although a comprehensive meta-analysis is lacking. In this …

As the world population ages, an expected increase in the prevalence of chronic kidney
disease (CKD) among older individuals will pose a considerable challenge for health care …